One of our precision oncology test Mammaprint, was the first FDA cleared IVDMIA breast cancer recurrence assay.
A biotechnology company focusing on novel biologics, biosimilars and novel diagnostics. A part of Kalbe Group and a subsidiary company of PT Kalbe Genexine Biologics (KGbio).
One of our precision oncology test Mammaprint, was the first FDA cleared IVDMIA breast cancer recurrence assay.
We have various drugs in key therapeutics areas such as biosimilars, novel cancer drugs and diagnostics, which are commercialized in most ASEAN countries.
We welcome collaborations in clinical development with companies which have strong science-based pipeline. We and our sister companies also provide laboratory services such as BA (Bioavailability) and BE (Bioequivalence) studies, CMO for biologics, and diagnostic services including biomarker.